Advances in therapeutic targeting of the DNA damage response in cancer

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• The DNA damage response (DDR) encompasses pathways crucial for repairing DNA lesions.
• DDR mechanisms are vital for cellular survival against various genomic insults.
• Tumor's DDR capability contributes significantly to radio and chemoresistance.

Purpose of the Study:

• To summarize recent advancements in targeting DDR proteins for cancer treatment.
• To project future breakthroughs and potential challenges in this therapeutic area.

Main Methods:

• Literature review of current research on DDR targeting in cancer therapy.
• Analysis of the role of DDR in therapeutic resistance.
• Projection of future research directions and clinical applications.

Main Results:

• DDR proteins are key targets for novel cancer therapies.
• Targeting DDR can potentially overcome resistance to traditional treatments.
• Advances in understanding DDR pathways are paving the way for personalized medicine.

Conclusions:

• Targeting the DNA damage response presents a significant therapeutic opportunity in oncology.
• Further research is needed to fully exploit DDR targeting and mitigate associated challenges.
• The field is progressing towards innovative strategies to enhance cancer treatment efficacy.